Decision: Favourable
Study Title:
A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Fragile X Syndrome – RECONNECT
NREC Code:
21-NREC-CT-156
Decision:
Favourable
Meeting Date:
08/12/2021
Study Type:
CT application
Principal Investigator:
Professor Louise Gallagher
PI Institution:
St James's Hospital
Sponsor:
Zynerba Pharmaceuticals, Inc